Specialty
Aesthetics Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

The Shifting Paradigm of Atopic Dermatitis – Part 1

By: Peter Lio, MD; Robert Sidbury, MD, MPH

This course has expired. You can still review the content but course credit is no longer available.

Webinar Credits: 1

This certified CME activity is designed for dermatologists, dermatology nurse practitioners and dermatology physician assistants involved in the management of atopic dermatitis.

Expiration Date: Saturday, June 30, 2018
Release Date: June 2017

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Identify the mechanisms of action, efficacy, and safety of emerging targeted therapies for AD.
  • Recognize the lifestyle measures and daily skin care practices that are the foundation of AD treatment plans.
  • Discuss the prevalence, presentation, and quality-of-life effects of AD in adults.
  • Interpret and explain the recognized and emerging comorbidities associated with AD in children, adolescents, and adults.

Accreditation and Designation Statement

Accreditation Statement
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement
Evolve Medical Education LLC designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Disclosures

The following faculty members have the following financial relationships with commercial interests:

Peter Lio, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Exeltis USA Dermatology, LLC; Galderma Laboratories L.P.; Johnson & Johnson; La Roche Posay; Pfizer Inc; Regeneron Pharmaceuticals, Inc.;  Sanofi Genzyme; and Valeant Pharmaceuticals International, Inc. Grant/Research Support: AO Biome and La Fondation pour la Dermatite Atopique

Robert Sidbury, MD has had no financial agreements or affiliations during the past year.

Editorial Support Disclosure

Kristin Richardson, Writer and Cheryl Cavanaugh, MS, Evolve Medical Education LLC have no real or apparent conflicts of interest to report.

Rishi P. Singh, MD, Peer Reviewer,  has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Alcon; Allergan  Inc.; Carl Zeiss Meditec; Genentech, Inc; Optos; Regeneron Pharmaceuticals, Inc; and Shire Plc. Grant/Research Support: Alcon; Apellis Pharmaceuticals; Genentech, Inc; and Regeneron Pharmaceuticals, Inc.

Video Resources

Part one

Part two

BackNext

This content is being presented as a live webinar broadcast. If you have participated in the live activity, please continue to the post test.

If you have not participated in the live activity, please check back soon for the enduring materials to be posted.

BackNext